Key Details
Price
$14.31Last Dividend
$0.50Annual Revenue
$23.52 MAnnual ROE
5.56%Beta
0.67Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
N/ARecent annual earnings:
N/ANext ex-dividend date:
N/ARecent ex-dividend date:
Nov 21, 2024Next split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
No data about analysts updates
Screeners with HQL included
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
HQL: Hold Your Investments In This Healthcare CEF For Strong, Steady Yield
HQL
Seeking Alpha27 September 2023
Tekla Life Sciences Investors invests primarily in biotechnology stocks, and 10-12 large-cap biotech stocks (50% of total holdings) sets the trend and price direction for this fund. Poor price growth of biotech stocks thus has resulted in a huge price loss for this fund. However, the HQL closed-end fund has delivered consistent strong yields over the years. Despite poor price growth, I am bullish about the biotech sector due to aging demographics, adoption of new medical products, and robust M&A activities.
HQL: 13% Discount Creates An Opportunity
HQL
Seeking Alpha29 June 2023
Tekla Life Sciences Investors is a closed-ended equity fund that primarily invests in the life sciences sector, with a heavy focus on biotech and pharmaceuticals.
FAQ
- What is the primary business of Tekla Life Sciences Investors?
- What is the ticker symbol for Tekla Life Sciences Investors?
- Does Tekla Life Sciences Investors pay dividends?
- What sector is Tekla Life Sciences Investors in?
- What industry is Tekla Life Sciences Investors in?
- What country is Tekla Life Sciences Investors based in?
- When did Tekla Life Sciences Investors go public?
- Is Tekla Life Sciences Investors in the S&P 500?
- Is Tekla Life Sciences Investors in the NASDAQ 100?
- Is Tekla Life Sciences Investors in the Dow Jones?
- When does Tekla Life Sciences Investors report earnings?
What is the primary business of Tekla Life Sciences Investors?
HQL (Tekla Life Sciences Investors) is a closed-end investment fund focused on the life sciences sector. It invests in biotechnology, pharmaceuticals, and medical technology companies, aiming to generate long-term capital growth for its shareholders through strategic investments in innovative healthcare solutions.
What is the ticker symbol for Tekla Life Sciences Investors?
The ticker symbol for Tekla Life Sciences Investors is NYSE:HQL
Does Tekla Life Sciences Investors pay dividends?
Yes, Tekla Life Sciences Investors pays dividends. The last payment was $0.50, with an ex-dividend date on 21 November 2024
What sector is Tekla Life Sciences Investors in?
Tekla Life Sciences Investors is in the Financial Services sector
What industry is Tekla Life Sciences Investors in?
Tekla Life Sciences Investors is in the Asset Management industry
What country is Tekla Life Sciences Investors based in?
Tekla Life Sciences Investors is headquartered in United States
When did Tekla Life Sciences Investors go public?
Tekla Life Sciences Investors's initial public offering (IPO) was on 01 May 1992
Is Tekla Life Sciences Investors in the S&P 500?
No, Tekla Life Sciences Investors is not included in the S&P 500 index
Is Tekla Life Sciences Investors in the NASDAQ 100?
No, Tekla Life Sciences Investors is not included in the NASDAQ 100 index
Is Tekla Life Sciences Investors in the Dow Jones?
No, Tekla Life Sciences Investors is not included in the Dow Jones index
When does Tekla Life Sciences Investors report earnings?
The date for Tekla Life Sciences Investors's next earnings report has not been announced yet